JFL Life Sciences filed its audited financial results for the quarter and year ended March 31, 2026, with the National Stock Exchange on May 30, 2026. The disclosure was made in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has made the detailed results accessible to shareholders and investors through its official website and the stock exchange portal.

The Board of Directors approved the financial statements, which have been audited. The results provide a comprehensive view of the company's financial performance for the specified period. The filing includes the necessary audit reports and financial statements as required by the regulatory framework.

Availability of Results

The complete audited financial results can be accessed via the following platforms:

• Company Website: https://jfllifesciences.com/
• NSE Website: www.nseindia.com

Investors can scan the Quick Response (QR) code provided in the regulatory filing to directly access the financial results. The submission ensures transparency and adherence to the disclosure norms mandated by the market regulator.

Regulatory Compliance

The filing confirms that JFL Life Sciences has met the regulatory deadlines for submitting its audited results. The document was signed by Smiral Ashwinkumar Patel, Managing Director, on behalf of the Board of Directors.